(45), who paused continuous subcutaneous insulin infusion (CSII) for 8 hours in patients with T1D, and found that IGFBP- 1 levels increased by 6-fold, whereas total and free IGF-I levels decreased. Here, IGFBP1 is linked to type 1 diabetes mellitus.